Bluesky Facebook Reddit Email

Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth

06.10.22 | Science China Press

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.


Epithelial ovarian cancer (EOC) exhibits strong dependency on the tricarboxylic acid (TCA) cycle and oxidative phosphorylation to fuel anabolic process. S -palmitoylation refers to the addition of the saturated 16-carbon fatty acid palmitate at a cysteine residue in protein to form a liable thioester bond. The S-palmitoylation modification alters the hydrophobic property of target proteins, regulating their cellular localization, trafficking, stability, activity, and signaling.

Recently, a paper entitled as “ Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth ” has been published in Science China-Life Sciences . Here, researchers show that malate dehydrogenase 2 (MDH2), a key enzyme of the TCA cycle, is palmitoylated at cysteine 138 (C138) residue, resulting in increased activity of MDH2. They next identify that ZDHHC18 acts as a palmitoyltransferase of MDH2. Glutamine deprivation enhances MDH2 palmitoylation by increasing the binding between ZDHHC18 and MDH2. MDH2 silencing represses mitochondrial respiration as well as ovarian cancer cell proliferation both in vitro and in vivo . Intriguingly, re-expression of wild-type MDH2, but not its palmitoylation-deficient C138S mutant, sustains mitochondrial respiration and restores the growth as well as clonogenic capability of ovarian cancer cells. Notably, MDH2 palmitoylation level is elevated in clinical cancer samples from patients with high-grade serous ovarian cancer.

These observations suggest that MDH2 palmitoylation catalyzed by ZDHHC18 sustains mitochondrial respiration and promotes the malignancy of ovarian cancer, yielding possibilities of targeting ZDHHC18-mediated MDH2 palmitoylation in the treatment of EOC.

Dr. Xuan Pei is the first author of this paper, Jia Qu and Qun-Ying Lei are the co-corresponding authors of this paper. The research was supported by the Ministry of Science and Technology, the National Natural Science Foundation of China and the Innovation Program of Shanghai Municipal Education Commission.

http://engine.scichina.com/doi/10.1007/s11427-021-2048-2

Science China Life Sciences

10.1007/s11427-021-2048-2

Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth

25-Mar-2022

Keywords

Article Information

Contact Information

Bei Yan
Science China Press
yanbei@scichina.org

How to Cite This Article

APA:
Science China Press. (2022, June 10). Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth. Brightsurf News. https://www.brightsurf.com/news/12DYOYE1/palmitoylation-of-mdh2-by-zdhhc18-activates-mitochondrial-respiration-and-accelerates-ovarian-cancer-growth.html
MLA:
"Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth." Brightsurf News, Jun. 10 2022, https://www.brightsurf.com/news/12DYOYE1/palmitoylation-of-mdh2-by-zdhhc18-activates-mitochondrial-respiration-and-accelerates-ovarian-cancer-growth.html.